Guardian Life Insurance’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-3,726
| Closed | -$242K | – | 189 |
|
2019
Q4 | $242K | Buy |
3,726
+21
| +0.6% | +$1.36K | 0.06% | 80 |
|
2019
Q3 | $235K | Buy |
3,705
+16
| +0.4% | +$1.02K | 0.04% | 91 |
|
2019
Q2 | $249K | Buy |
3,689
+17
| +0.5% | +$1.15K | 0.03% | 88 |
|
2019
Q1 | $239K | Hold |
3,672
| – | – | 0.03% | 88 |
|
2018
Q4 | $230K | Buy |
3,672
+15
| +0.4% | +$940 | 0.04% | 83 |
|
2018
Q3 | $282K | Buy |
3,657
+61
| +2% | +$4.7K | 0.05% | 76 |
|
2018
Q2 | $255K | Buy |
3,596
+590
| +20% | +$41.8K | 0.04% | 74 |
|
2018
Q1 | $227K | Sell |
3,006
-1,223
| -29% | -$92.4K | 0.04% | 68 |
|
2017
Q4 | $303K | Buy |
4,229
+1,266
| +43% | +$90.7K | 0.07% | 71 |
|
2017
Q3 | $240K | Buy |
2,963
+7
| +0.2% | +$567 | 0.04% | 64 |
|
2017
Q2 | $209K | Sell |
2,956
-2,093
| -41% | -$148K | 0.03% | 59 |
|
2017
Q1 | $343K | Buy |
5,049
+1
| +0% | +$68 | 0.05% | 66 |
|
2016
Q4 | $361K | Buy |
5,048
+67
| +1% | +$4.79K | 0.05% | 74 |
|
2016
Q3 | $394K | Sell |
4,981
-144
| -3% | -$11.4K | 0.04% | 100 |
|
2016
Q2 | $428K | Sell |
5,125
-206
| -4% | -$17.2K | 0.03% | 120 |
|
2016
Q1 | $490K | Sell |
5,331
-1,509
| -22% | -$139K | 0.04% | 109 |
|
2015
Q4 | $692K | Sell |
6,840
-1,741
| -20% | -$176K | 0.07% | 96 |
|
2015
Q3 | $843K | Buy |
8,581
+2,141
| +33% | +$210K | 0.09% | 93 |
|
2015
Q2 | $754K | Sell |
6,440
-75
| -1% | -$8.78K | 0.07% | 91 |
|
2015
Q1 | $639K | Sell |
6,515
-2,084
| -24% | -$204K | 0.06% | 103 |
|
2014
Q4 | $811K | Hold |
8,599
| – | – | 0.08% | 102 |
|
2014
Q3 | $915K | Sell |
8,599
-127
| -1% | -$13.5K | 0.09% | 91 |
|
2014
Q2 | $723K | Buy |
8,726
+89
| +1% | +$7.37K | 0.07% | 101 |
|
2014
Q1 | $612K | Hold |
8,637
| – | – | 0.05% | 113 |
|
2013
Q4 | $649K | Sell |
8,637
-9,764
| -53% | -$734K | 0.06% | 114 |
|
2013
Q3 | $1.16M | Buy |
18,401
+80
| +0.4% | +$5.03K | 0.1% | 112 |
|
2013
Q2 | $938K | Buy |
+18,321
| New | +$938K | 0.09% | 116 |
|